Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annu...(ice President in the Clinical Developmen...)

Date:6/17/2008

ice President in the Clinical Development practice. He specializes in helping clients improve their clinical development operations and business processes to optimize the flow of critical information, increase the efficacy of key processes, and enhance organizational capabilities. Mr. Dietlin earned his MBA from DePaul University's Kellstadt Graduate School of Business and has a BA from Loyola University of Chicago.

On the day after Mr. Dietlin's workshop, Tuesday, June 24, Mr. Tyson will conduct a workshop titled "Becoming a Sponsor of Choice for Clinical Investigators" from 8:00 am to 9:30 am. The workshop, which is part of the Clinical Trial Management/Clinical Supplies track, will discuss key factors driving investigators' choices of clinical study sponsors. It will also explore tactics for identifying a pharmaceutical or biotech company's strengths and weaknesses with respect to conducting clinical trials, as well as examine strategies for improving a company's relationship with the study sites and investigators it values most.

"It's critical that a pharmaceutical company do everything it can to be the study sponsor that sites prefer to work with -- the sponsor of choice -- because there are so many clinical trials that are competing for the same patients," Mr. Tyson said. "Companies will gain a clear advantage if they understand what's behind an investigator's or study site's decision to work with a particular sponsor," he said.

As the head of Campbell Alliance's Clinical Development Practice, Mr. Tyson leads a team that provides a range of operational improvement services to clinical development organizations within pharmaceutical and biotech companies, as well as at leading contract research organizations (CROs). He is a veteran of numerous electronic-data-capture-related initiatives, and brings a wealth of knowledge and experience in process improvement, organizational design, and clinical development to his consulting engagements.

'/>"/>

SOURCE Campbell Alliance Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Campbell Alliance to Moderate Senior-Level Panel Discussion at Windhover Pharmaceutical Strategic Alliances Conference
2. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
3. Campbell Alliance Named Best Place to Work by Triangle Business Journal
4. Campbell Alliance Business Development Practice to Moderate Two Workshops at LES Annual Meeting in Vancouver
5. Campbell Alliance Launches New Practice Area Focused on Trade and Distribution
6. Campbell Alliance Trade and Distribution Practice to Chair CBI 3rd Annual Fee for Service and EDI Data Management Conference
7. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
8. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
9. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
10. Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies
11. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group